World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
46837
World Ranking
7263
National Ranking
79

Overview

Rui-Hua Xu is affiliated with Sun Yat-sen University in China and has extensive research activity primarily focused on medicine, with significant contributions in oncology and molecular biology.

The scientist has published more than one thousand works in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, Rui-Hua Xu's research has notably concentrated on subfields including:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Surgery
  • Cancer Research

The main topics covered in Rui-Hua Xu's work encompass:

  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Esophageal Cancer Research and Treatment

Rui-Hua Xu has contributed to a range of recent scholarly papers, including:

  • "Circular RNA: metabolism, functions and interactions with proteins" (2020) published in Molecular Cancer
  • "Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020" (2021) published in Cancer Communications
  • "Gastric cancer treatment: recent progress and future perspectives" (2023) published in Journal of Hematology & Oncology
  • "Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (2021) published in JAMA
  • "LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer" (2020) published in Cancer Communications

Frequent coauthors collaborating with Rui-Hua Xu include:

  • Feng Wang
  • Miao-Zhen Qiu
  • Huai-Qiang Ju
  • Feng-Hua Wang
  • Hui Luo

Key publication venues where Rui-Hua Xu's work regularly appears include:

  • Journal of Clinical Oncology
  • Cancer Communications
  • Annals of Oncology
  • Nature Communications
  • PubMed

Best Publications

  • Glycolysis inhibition for anticancer treatment

    Helene Pelicano;D. S. Martin;Rui-Hua Xu;Peng Huang

  • Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics?

    Rui Mei Feng;Yi Nan Zong;Su Mei Cao;Rui Hua Xu

  • Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

    Rui Hua Xu;Helene Pelicano;Yan Zhou;Jennifer S. Carew

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

    Jin Li;Shukui Qin;Jianming Xu;Jianping Xiong

  • Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

    Jin Li;Shukui Qin;Rui-Hua Xu;Thomas C C Yau

  • Circular RNA: metabolism, functions and interactions with proteins

    Wei-Yi Zhou;Ze-Rong Cai;Jia Liu;De-Shen Wang

  • Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

    Rui Hua Xu;Wei Wei;Wei Wei;Michal Krawczyk;Wenqiu Wang

  • Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study

    Taroh Satoh;Rui-Hua Xu;Hyun Cheol Chung;Guo-Ping Sun

  • The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer.

    Feng Hua Wang;Lin Shen;Jin Li;Zhi Wei Zhou

  • METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

    Ting Li;Pei Shan Hu;Zhixiang Zuo;Jin Fei Lin

  • Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.

    Haibo Qiu;Sumei Cao;Ruihua Xu

  • N 6 -methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

    Ri-Xin Chen;Xin Chen;Liang-Ping Xia;Jia-Xing Zhang

  • Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial

    Huiyan Luo;Huiyan Luo;Jin Lu;Yuxian Bai;Teng Mao

  • LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer

    Yue-Tao Tan;Jin-Fei Lin;Ting Li;Jia-Jun Li

  • DNA methylation markers for diagnosis and prognosis of common cancers.

    Xiaoke Hao;Huiyan Luo;Michal Krawczyk;Wei Wei;Wei Wei

  • Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432.

    F. Wang;X.L. Wei;F.H. Wang;N. Xu

  • LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

    Yun Wang;Jia Huan Lu;Jia Huan Lu;Qi Nian Wu;Ying Jin

  • Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism

    Helene Pelicano;Rui-Hua Xu;Min Du;Li Feng

  • Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study

    Huiyan Luo;Guoliang Xu;Chaofeng Li;Longjun He

  • Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types.

    Feng Wang;Qi Zhao;Ying Nan Wang;Ying Jin

Frequent Co-Authors

Dan Xie
Dan Xie Sun Yat-sen University
Jianming Xu
Jianming Xu Zhejiang University
Peng Huang
Peng Huang Sun Yat-sen University
Yongqian Shu
Yongqian Shu Nanjing Medical University
Yi Ba
Yi Ba Beijing Institute of Genomics
Xiaojun Wu
Xiaojun Wu University of Science and Technology of China
Kei Muro
Kei Muro National Cancer Research Institute, UK
Satoshi Morita
Satoshi Morita Kyoto University
Li Zhang
Li Zhang Sun Yat-sen University
Yung-Jue Bang
Yung-Jue Bang Seoul National University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn’t always lead to a traditional MD. Many students consider alternative roles in healthcare that offer rewarding careers and more flexible study routes. For those interested in entering the workforce quickly, lpn programs provide a fast track to becoming a licensed practical nurse. These programs can often be completed online, making it easier for you to juggle studies with other responsibilities.

If you’re drawn to mental health care, online pmhnp programs prepare you to become a Psychiatric Mental Health Nurse Practitioner. These specialized degrees let you address crucial mental wellness needs, with many accelerated options available.

Leadership roles in health services are also in high demand. Pursuing online healthcare administration programs can lead to management positions that ensure quality patient care and efficient operations. For advanced study, the cheapest online mha degrees make it financially accessible to gain those executive skills.

No matter your passion—direct care or health leadership—flexible, affordable online degrees offer excellent entry points to the broader medical field.

Best Scientists Citing Rui-Hua Xu

Trending Scientists